EFFICACY AND TOLERABILITY OF A SINGLE-DAY THREE DRUG COMBINATION OF APREPITANT, PALONOSETRON AND DEXAMETHASONE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY

被引：0
|
作者：
Quadrini, S. [1 ]
Longo, F. [1 ]
Lapadula, V [1 ]
Stumbo, L. [1 ]
De Sanctis, R. [1 ]
D'Antoni, I [1 ]
Del Signore, E. [1 ]
Gori, B. [1 ]
Viggiani, E. [1 ]
Vairano, M. [1 ]
Di Seri, M. [1 ]
机构：
[1] Policlin Umberto 1, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study
    Kitayama, Hiromitsu
    Tsuji, Yasushi
    Sugiyama, Junko
    Doi, Ayako
    Kondo, Tomohiro
    Hirayama, Michiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (06) : 1051 - 1056
  • [22] Palonosetron versus Granisetron in Combination with Aprepitant and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy: A Single-Institutional Retrospective Cohort Study
    Miyoshi, Takanori
    Miyashita, Hiroo
    Matsuo, Naomi
    Odawara, Miki
    Hori, Minako
    Hiraki, Yoichi
    Kawanaka, Hirofumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (10) : 1413 - 1418
  • [23] Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study
    Hiromitsu Kitayama
    Yasushi Tsuji
    Junko Sugiyama
    Ayako Doi
    Tomohiro Kondo
    Michiaki Hirayama
    International Journal of Clinical Oncology, 2015, 20 : 1051 - 1056
  • [24] Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy
    Shota Hamada
    Shiro Hinotsu
    Koji Kawai
    Shigeyuki Yamada
    Shintaro Narita
    Tomomi Kamba
    Hiroyuki Nishiyama
    Yoichi Arai
    Tomonori Habuchi
    Osamu Ogawa
    Koji Kawakami
    Supportive Care in Cancer, 2014, 22 : 2161 - 2166
  • [25] Single-day regimen of palonosetron (PALO) and dexamethasone (DEX) for the prevention of emesis associated with moderately emetogenic chemotherapy (MEC): Subgroup analysis from a randomized phase III trial
    Celio, L.
    Bajetta, E.
    Denaro, A.
    Bichisao, E.
    Frustaci, S.
    Ardizzoia, A.
    Piazza, E.
    Fabi, A.
    Capobianco, A.
    Isa, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy
    Warr, DG
    Hesketh, PJ
    Gralla, RJ
    Muss, HB
    Herrstedt, J
    Eisenberg, PD
    Raftopoulos, H
    Grunberg, SM
    Gabriel, M
    Rodgers, A
    Bohidar, N
    Klinger, G
    Hustad, CM
    Horgan, KJ
    Skobieranda, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2822 - 2830
  • [27] Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting
    Kwon, J. H.
    Kang, J-H.
    Lee, Y-G.
    Park, K. U.
    An, H. J.
    Sohn, J.
    Seol, Y. M.
    Lee, H.
    Yun, H-J.
    Ahn, J. S.
    Kim, H. J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] THE EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON (PALO), APREPITANT (APR), AND DEXAMETHASONE (DEX)
    Yoshizawa, H.
    Sato, K.
    Makino, M.
    Kobayashi, O.
    Tanaka, H.
    Miura, S.
    Watanabe, S.
    Tanaka, J.
    Kagamu, H.
    Ichiei, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 509 - 509
  • [29] Palonosetron plus aprepitant and dexamethasone is a highly effective combination to prevent chemotherapy-induced nausea & vomiting after emetogenic chemotherapy
    Grote, T.
    Hajdenberg, J.
    Cartmell, A.
    Ferguson, S.
    Gallagher, S.
    Piraccini, G.
    Charu, V.
    EJC SUPPLEMENTS, 2005, 3 (02): : 371 - 372
  • [30] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    International Journal of Clinical Oncology, 2017, 22 : 600 - 604
12345